PSI's Attempt to Create Standards Draws Mixed Reviews; PSI Concedes Need to 'Better Sell Job' | GenomeWeb
Washington, DC — As leaders and members of the Human Proteome Organization’s Proteomics Standards Initiatives convened here this week for their annual fall workshop, initial feedback from reviewers of PSI’s plan to develop and issue reporting standards revealed deep skepticism and anxiety.
 
At the workshop, about 70 scientists and researchers met to get an update on the numerous efforts underway to create standards for proteomics and to continue building a roadmap for further work.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.